New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Report: Disease history doubles rate of colorectal cancer screening for family members

Report: Disease history doubles rate of colorectal cancer screening for family members

by BGI GenomicsHas respondents with CRC family history ever taken family members for screening? Credit: BGI GenomicsTo uncover attitudes and the biggest challenges facing colorectal cancer (CRC) aware
World medicine December 06,2023
Report: Disease history doubles rate of colorectal cancer screening for family members

Report: Disease history doubles rate of colorectal cancer screening for family members

by BGI GenomicsHas respondents with CRC family history ever taken family members for screening? Credit: BGI GenomicsTo uncover attitudes and the biggest challenges facing colorectal cancer (CRC) aware
World medicine December 06,2023
Report: Over 60% of Saudi Arabian respondents have never taken a colorectal cancer test

Report: Over 60% of Saudi Arabian respondents have never taken a colorectal cancer test

by BGI GenomicsKaplan-Meier Survival Rate by Stage. Credit:BMC Cancer(2021). DOI: 10.1186/s12885-021-08705-8Colorectal cancer (CRC) is the most diagnosed cancer among males and third among
World medicine December 06,2023
Report: Over 60% of Saudi Arabian respondents have never taken a colorectal cancer test

Report: Over 60% of Saudi Arabian respondents have never taken a colorectal cancer test

by BGI GenomicsKaplan-Meier Survival Rate by Stage. Credit:BMC Cancer(2021). DOI: 10.1186/s12885-021-08705-8Colorectal cancer (CRC) is the most diagnosed cancer among males and third among
World medicine December 06,2023
Report: Impact of COVID-19 on cancer center clinical trials operations

Report: Impact of COVID-19 on cancer center clinical trials operations

by Association of American Cancer Institutes (AACI)Credit: Unsplash/CC0 Public DomainLeveraging its network of leading North American cancer centers, the Association of American Cancer Institutes (AAC
World medicine December 06,2023
Report: Impact of COVID-19 on cancer center clinical trials operations

Report: Impact of COVID-19 on cancer center clinical trials operations

by Association of American Cancer Institutes (AACI)Credit: Unsplash/CC0 Public DomainLeveraging its network of leading North American cancer centers, the Association of American Cancer Institutes (AAC
World medicine December 06,2023
Disparities seen in geographic access to fertility preservation

Disparities seen in geographic access to fertility preservation

by Lori SolomonMore than 3 million reproductive-age females lack geographic access to centers capable of offering fertility preservation (FP) services, according to a study published online Aug. 10 in
World medicine December 06,2023
Disparities seen in geographic access to fertility preservation

Disparities seen in geographic access to fertility preservation

by Lori SolomonMore than 3 million reproductive-age females lack geographic access to centers capable of offering fertility preservation (FP) services, according to a study published online Aug. 10 in
World medicine December 06,2023
Bladder cancer: What you should know about diagnosis, treatment and recurrence

Bladder cancer: What you should know about diagnosis, treatment and recurrence

byMayo ClinicCredit: Unsplash/CC0 Public DomainBladder cancer is one of the most common cancer types in the U.S., according to the National Cancer Institute. It's also one of the most likely
World medicine December 06,2023
Bladder cancer: What you should know about diagnosis, treatment and recurrence

Bladder cancer: What you should know about diagnosis, treatment and recurrence

byMayo ClinicCredit: Unsplash/CC0 Public DomainBladder cancer is one of the most common cancer types in the U.S., according to the National Cancer Institute. It's also one of the most likely
World medicine December 06,2023
Targeting the Src N-Terminal regulatory element in cancer

Targeting the Src N-Terminal regulatory element in cancer

by Impact Journals LLCCanonical Src regulation involves the transition from an inactive closed state to an active open form. Credit: 2023 Mezquita et al.A new research perspective was published in&nbs
World medicine December 06,2023
Targeting the Src N-Terminal regulatory element in cancer

Targeting the Src N-Terminal regulatory element in cancer

by Impact Journals LLCCanonical Src regulation involves the transition from an inactive closed state to an active open form. Credit: 2023 Mezquita et al.A new research perspective was published in&nbs
World medicine December 06,2023
Targeted therapy achieves responses across multiple cancer types with FGFR alterations

Targeted therapy achieves responses across multiple cancer types with FGFR alterations

byUniversity of Texas M. D. Anderson Cancer CenterPrimary analysis results from RAGNAR, the largest tumor agnostic trial of targeted tx to date, confirm efficacy of erda in heavily pretreated pt
World medicine December 06,2023
Targeted therapy achieves responses across multiple cancer types with FGFR alterations

Targeted therapy achieves responses across multiple cancer types with FGFR alterations

byUniversity of Texas M. D. Anderson Cancer CenterPrimary analysis results from RAGNAR, the largest tumor agnostic trial of targeted tx to date, confirm efficacy of erda in heavily pretreated pt
World medicine December 06,2023
Targeting cellular respiration as a therapeutic strategy in glioblastoma

Targeting cellular respiration as a therapeutic strategy in glioblastoma

by Impact Journals LLCInhibitors of mitochondrial respiration. Credit: 2023 Shang et al.A new research perspective, titled "Targeting cellular respiration as a therapeutic strategy in glioblastom
World medicine December 06,2023
Targeting cellular respiration as a therapeutic strategy in glioblastoma

Targeting cellular respiration as a therapeutic strategy in glioblastoma

by Impact Journals LLCInhibitors of mitochondrial respiration. Credit: 2023 Shang et al.A new research perspective, titled "Targeting cellular respiration as a therapeutic strategy in glioblastom
World medicine December 06,2023
Targeting uncontrolled inflammation may hold the key to treating therapy-resistant cancers

Targeting uncontrolled inflammation may hold the key to treating therapy-resistant cancers

byVan Andel Research InstituteGraphical Abstract. Credit:Molecular Cell(2023). DOI: 10.1016/j.molcel.2023.04.017Van Andel Institute scientists have pinpointed how a specific gene mut
World medicine December 06,2023
Targeting uncontrolled inflammation may hold the key to treating therapy-resistant cancers

Targeting uncontrolled inflammation may hold the key to treating therapy-resistant cancers

byVan Andel Research InstituteGraphical Abstract. Credit:Molecular Cell(2023). DOI: 10.1016/j.molcel.2023.04.017Van Andel Institute scientists have pinpointed how a specific gene mut
World medicine December 06,2023
Targeting GITR in cancer immunotherapy

Targeting GITR in cancer immunotherapy

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new research perspective titled "Targeting GITR in cancer immunotherapy—there is no perfect knowledge" has been published inOnc
World medicine December 06,2023
Targeting GITR in cancer immunotherapy

Targeting GITR in cancer immunotherapy

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new research perspective titled "Targeting GITR in cancer immunotherapy—there is no perfect knowledge" has been published inOnc
World medicine December 06,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com